Moraga, California
United States
61
2025-04-17
The entities that hold a legal rights for patent applications filed by inventor Wang Weibo:
Weibo Wang from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOUNDS AS BCL-2 INHIBITORS
#2 | 2023-12-21SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
#3 | 2023-06-08COMPOUNDS AS PROTEIN KINASE INHIBITORS
#4 | 2023-05-25COMPOUNDS AS BCL-2 INHIBITORS
#5 | 2023-05-11COMPOUNDS USEFUL AS KINASE INHIBITORS
#6 | 2023-05-04COMPOUNDS AS CDK2/4/6 INHIBITORS
#7 | 2022-12-22Apoptosis-inducing agents
#8 | 2022-11-10HETEROCYCLIC DERIVATIVES AND USE THEREOF
#9 | 2022-07-28SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3,4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
#10 | 2022-02-10SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#11 | 2021-05-13Macrocyclic compounds as TRK kinases inhibitors
#12 | 2021-03-11Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase
#13 | 2021-03-11Deuterated compounds as rock inhibitors
#14 | 2021-01-28Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors
#15 | 2020-04-16Apoptosis-inducing agents
#16 | 2020-04-16Indolizine derivatives, composition and methods of use
#17 | 2019-11-14Compounds as BLC-2-selective apoptosis-inducing agents
#18 | 2019-07-11Certain protein kinase inhibitors
#19 | 2019-05-30Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors
#20 | 2018-10-11Certain protein kinase inhibitor
#21 | 2018-02-08Certain protein kinase inhibitors
#22 | 2017-09-21Certain protein kinase inhibitors
#23 | 2017-09-21Quinazoline derivatives, compositions thereof, and use as pharmaceuticals
#24 | 2017-04-20Certain protein kinase inhibitors
#25 | 2016-06-16Quinazoline derivatives, compositions thereof, and use as pharmaceuticals
#26 | 2016-05-26CERTAIN PROTEIN KINASE INHIBITORS
#27 | 2016-03-24Certain protein kinase inhibitors
#28 | 2016-02-18Certain protein kinase inhibitors
#29 | 2015-10-08CERTAIN DIPEPTIDYL PEPTIDASE INHIBITORS
#30 | 2014-07-31Certain dipeptidyl peptidase inhibitors
#31 | 2014-05-08Certain protein kinase inhibitors
#32 | 2013-01-17Substituted imidazole derivates
#33 | 2012-09-066-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
#34 | 2012-07-26CYCLIZED DERIVATIVES AS EG-5 INHIBITORS
#35 | 2011-08-04Quinazolinone Compounds as Anticancer Agents
#36 | 2011-06-30Certain dipeptidyl peptidase inhibitors
#37 | 2011-01-06Cyclized Derivatives as EG-5 Inhibitors
#38 | 2010-11-046-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
#39 | 2010-10-14CSF-1R, Inhibitors, Compositions, and Methods of Use
#40 | 2010-02-25Quinazolines for PDK1 inhibition
#41 | 2009-11-19Thiosemicarbazones as anti-virals and immunopotentiators
#42 | 2009-10-15Substituted imidazole derivatives
#43 | 2009-07-02MITOTIC KINESIN INHIBITORS
#44 | 2009-01-29SUBSTITUTED QUINOLINE DERIVATIVES
#45 | 2008-12-25Indole and benzimidazole derivatives
#46 | 2008-12-18Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
#47 | 2008-10-09Mitotic Kinesin Inhibitors
#48 | 2008-08-28Cyclized derivatives as Eg-5 inhibitors
#49 | 2008-03-20HETEROARYL-FUSED PYRIMIDINYL COMPOUNDS AS ANTICANCER AGENTS
#50 | 2008-02-216-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
#51 | 2007-11-29Compositions and Methods for Viral Inhibition
#52 | 2007-02-15Substituted imidazole compounds as KSP inhibitors
#53 | 2006-04-20Indole and benzimidazole derivatives
#54 | 2006-01-12Substituted imidazole derivatives
#55 | 2005-11-24Substituted quinoline derivatives
#56 | 2005-10-13Mitotic kinesin inhibitors
#57 | 2005-09-29Tetrahydrocarboline compounds as anticancer agents
#58 | 2005-09-22Quinazolinone compounds as anticancer agents
#59 | 2005-04-21Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
#60 | 2005-03-31Thiosemicarbazones as anti-virals and immunopotentiators
#61 | 2005-03-24Heteroaryl-fused pyrimidinyl compounds as anticancer agents
40166 ⎘